Clinical trial
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial…
NCT00072540 · SWOG Cancer Research Network, Other · Withdrawn
Key facts
| NCT number | NCT00072540 |
|---|---|
| Title | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix |
| Official title | S0212: Phase IIb Randomized Study of Celecoxib in Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage 0 Cervical Cancer, High-grade Squamous Intraepithelial Lesion |
| Intervention type | Drug, Procedure |
| Interventions | celecoxib, anti-cytokine therapy, antiangiogenesis therapy, biological therapy, cancer prevention intervention, chemoprevention of cancer, enzyme inhibitor therapy, growth factor antagonist therapy |
| Enrollment | 0 |
| First posted | Nov 5, 2003 |
| Last update posted | Nov 8, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: